entertainment -WSS

entertainment

author：focus 2025-10-01 01:50:28 - browse：8319

Colorful one hundred dollar bills -- health tech coverage from STAT — Adobe

Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Why did Pfizer dish out millions for a Super Bowl ad?

WSS

Four alarming medical procedures we’re glad history forgot

Insurer loopholes limit power of law against surprise medical bills

Medicare Advantage 2025 payments will dip, Biden administration says

For Medicare Advantage, Democrats want stronger protections around AI

Robert F. Kennedy is pitching centrism on health, even on abortion

Biogen Alzheimer’s drug launch off to slow start

entertainment

entertainment

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Overprescribed: High cost isn't America's only drug problem

DIEP, the 'gold standard' of breast reconstruction, is under threat

Overprescribed: High cost isn't America's only drug problem

After affirmative action ruling, medical educators look to 'holistic review'

Biden report: The neurospychology of memory and aging

Psychedelics group wrestles with new pharma identity

PhRMA lawsuit over Medicare drug price negotiation tossed

Novavax promises a turnaround & Lilly roils the obesity market

Insurer loopholes limit power of law against surprise medical bills

leisure time

PhRMA lawsuit over Medicare drug price negotiation tossed

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Medicare threatens to cut off funding for HCA's Mission hospital

Multiple sclerosis has subtypes with different best treatments: study

How digital tools helped lower hypertension in marginalized patients

focus

leisure time

focus

leisure time